OPCON Drug Patent Profile
✉ Email this page to a colleague
When do Opcon patents expire, and when can generic versions of Opcon launch?
Opcon is a drug marketed by Bausch And Lomb and is included in two NDAs.
The generic ingredient in OPCON is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Opcon
A generic version of OPCON was approved as naphazoline hydrochloride; pheniramine maleate by ALTAIRE PHARMS INC on September 27th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OPCON?
- What are the global sales for OPCON?
- What is Average Wholesale Price for OPCON?
Summary for OPCON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 91 |
| Patent Applications: | 1,963 |
| DailyMed Link: | OPCON at DailyMed |
US Patents and Regulatory Information for OPCON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb | OPCON | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 087506-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb | OPCON-A | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 020065-001 | Jun 8, 1994 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
